The Scientist

» bioengineering and culture

Most Recent

image: Staying Active in the Lab

Staying Active in the Lab

By | July 1, 2015

Retiring as a professor, and even shutting down your own lab, doesn’t necessarily mean quitting research.

8 Comments

image: The War Rages On

The War Rages On

By | July 1, 2015

Retiring as a professor, and even shutting down your own lab, doesn’t necessarily mean quitting research.

5 Comments

image: Keeping Science Pubs Clean

Keeping Science Pubs Clean

By | June 29, 2015

Retiring as a professor, and even shutting down your own lab, doesn’t necessarily mean quitting research.

0 Comments

image: Casting a Small Net

Casting a Small Net

By | June 10, 2015

Retiring as a professor, and even shutting down your own lab, doesn’t necessarily mean quitting research.

0 Comments

image: Limbs in the Lab

Limbs in the Lab

By | June 8, 2015

Retiring as a professor, and even shutting down your own lab, doesn’t necessarily mean quitting research.

0 Comments

Retiring as a professor, and even shutting down your own lab, doesn’t necessarily mean quitting research.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | June 1, 2015

Retiring as a professor, and even shutting down your own lab, doesn’t necessarily mean quitting research.

0 Comments

image: Reimagining Humanity

Reimagining Humanity

By | June 1, 2015

Retiring as a professor, and even shutting down your own lab, doesn’t necessarily mean quitting research.

0 Comments

image: Alternate Pathways Yield New Antibiotics

Alternate Pathways Yield New Antibiotics

By | May 29, 2015

Retiring as a professor, and even shutting down your own lab, doesn’t necessarily mean quitting research.

0 Comments

Retiring as a professor, and even shutting down your own lab, doesn’t necessarily mean quitting research.

28 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech